RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
The purpose of this study was to determine if intravitreal ranibizumab is superior to laser ablation therapy in the treatment of retinopathy of prematurity (ROP).
The study consisted of a screening period (screening and randomization could occur up to 3 days before the administration of the first investigational treatment), followed by a treatment and follow-up period (Day 1 to Day 169).
Inclusion Criteria:
Exclusion Criteria:
Ostrava Poruba, Czech Republic 708 52, Czechia
Praha 4 - Podoli, Czech Republic 14700, Czechia
Koebenhavn Ø, 2100, Denmark
Goudi- Athens, 115 27, Greece
Shimajiri-Gun, Okinawa 901-1303, Japan
Ohtsu-city, Shiga 520-2192, Japan
Setagaya-ku, Tokyo 157-8535, Japan
Sumida-ku, Tokyo 130-8575, Japan
Toshima-ku, Tokyo 170-8476, Japan
Querataro, 76090, Mexico
Soguksu / Antalya, Turkey 07100, Turkey (Türkiye)
Zuhuratbaba / Istanbul, Turkey 34147, Turkey (Türkiye)